{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:27:21Z","timestamp":1793608041949,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma &amp; Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.anai.2026.02.005","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:53:58Z","timestamp":1772096038000},"page":"706-711.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prospective outcomes of penicillin allergy evaluation"],"prefix":"10.1016","volume":"136","author":[{"given":"Weihong","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadence O.K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5085-0837","authenticated-orcid":false,"given":"Hugo W.F.","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9155-9162","authenticated-orcid":false,"given":"Philip H.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 6","key":"10.1016\/j.anai.2026.02.005_bib0001","first-page":"vi13","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe (1997-2009)","volume":"66","author":"Versporten","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.anai.2026.02.005_bib0002","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1473-3099(25)00091-X","article-title":"Tackling the burden of beta-lactam allergy labels","volume":"25","author":"Li","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.anai.2026.02.005_bib0003","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S1473-3099(25)00019-2","article-title":"The burden of beta-lactam allergy labels in health care: a systematic review and meta-analysis","volume":"25","author":"Fu","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.anai.2026.02.005_bib0004","doi-asserted-by":"crossref","first-page":"463","DOI":"10.18176\/jiaci.1106","article-title":"Disparities in drug allergy labeling in china: half of all labels are attributed to ss-lactams","volume":"35","author":"Shi","year":"2025","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.anai.2026.02.005_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2022.1059321","article-title":"Differences in beta-lactam and penicillin allergy: beyond the West and focusing on Asia-Pacific","volume":"3","author":"Mak","year":"2022","journal-title":"Front Allergy"},{"issue":"5","key":"10.1016\/j.anai.2026.02.005_bib0006","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.4199","article-title":"Prevalence, Incidence, and Sensitization Profile of beta-lactam antibiotic Allergy in Hong Kong","volume":"3","author":"Li","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.anai.2026.02.005_bib0007","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12916-024-03250-0","article-title":"Identifying the most at-risk age-group and longitudinal trends of drug allergy labeling amongst 7.3 million individuals in Hong Kong","volume":"22","author":"Chiang","year":"2024","journal-title":"BMC Med"},{"issue":"8","key":"10.1016\/j.anai.2026.02.005_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2019.100048","article-title":"Beta-lactam allergy in Chinese patients and factors predicting genuine allergy","volume":"12","author":"Li","year":"2019","journal-title":"World Allergy Organ J"},{"issue":"1","key":"10.1016\/j.anai.2026.02.005_bib0009","doi-asserted-by":"crossref","first-page":"10","DOI":"10.12932\/AP-270922-1469","article-title":"Prospective Assessment of Penicillin Allergy (PAPA): evaluating the performance of penicillin allergy testing and post-delabelling outcomes among Hong Kong Chinese","volume":"43","author":"Li","year":"2025","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"3","key":"10.1016\/j.anai.2026.02.005_bib0010","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2013.09.021","article-title":"Health care use and serious infection prevalence associated with penicillin \u201callergy\u201d in hospitalized patients: a cohort study","volume":"133","author":"Macy","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.anai.2026.02.005_bib0011","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/cid\/ciw462","article-title":"Impact of reported beta-lactam allergy on inpatient outcomes: a multicenter prospective cohort study","volume":"63","author":"MacFadden","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.anai.2026.02.005_bib0012","first-page":"192","article-title":"Epidemiology and outcomes of geriatric and non-geriatric patients with drug allergy labels in Hong Kong","volume":"27","author":"Li","year":"2021","journal-title":"HK Med J"},{"issue":"10","key":"10.1016\/j.anai.2026.02.005_bib0013","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1016\/j.jaip.2023.06.025","article-title":"The burden of self-reported antibiotic allergies in health care and how to address it: a systematic review of the evidence","volume":"11","author":"Arnold","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2026.02.005_bib0014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5415\/apallergy.0000000000000020","article-title":"Validation of the Chinese drug hypersensitivity Quality of Life Questionnaire: role of delabeling","volume":"13","author":"Mak","year":"2023","journal-title":"Asia Pac Allergy"},{"issue":"1","key":"10.1016\/j.anai.2026.02.005_bib0015","article-title":"A rapid literature review of the impact of penicillin allergy on antibiotic resistance","volume":"7","author":"Ahmed","year":"2025","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.anai.2026.02.005_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2022.974138","article-title":"Hong Kong Drug Allergy Delabelling Initiative (HK-DADI) consensus statements for penicillin allergy testing by nonallergists","volume":"3","author":"Li","year":"2022","journal-title":"Front Allergy"},{"issue":"2","key":"10.1016\/j.anai.2026.02.005_bib0017","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jaip.2022.08.052","article-title":"Comparative effectiveness, safety, and real-world outcomes of a nurse-led, protocol-driven penicillin allergy evaluation from the Hong Kong Drug Allergy Delabelling Initiative (HK-DADI)","volume":"11","author":"Kan","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.anai.2026.02.005_bib0018","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.jaip.2024.04.010","article-title":"Prospective, multicenter, head-to-head comparison between allergists versus nonallergists in low-risk penicillin allergy delabeling: effectiveness, safety, and quality of life (HK-DADI2)","volume":"12","author":"Wong","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"10.1016\/j.anai.2026.02.005_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2024.101003","article-title":"Comparing pharmacists versus allergists in low-risk penicillin allergy delabelling: the Hong Kong Penicillin Allergy Pharmacist Initiative (HK-PAPI)","volume":"17","author":"Hooi","year":"2024","journal-title":"World Allergy Organ J"},{"issue":"4","key":"10.1016\/j.anai.2026.02.005_bib0020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5415\/apallergy.0000000000000122","article-title":"APAAACI clinical pathway on direct provocation testing for penicillin allergy delabeling","volume":"13","author":"Li","year":"2023","journal-title":"Asia Pac Allergy"},{"issue":"2","key":"10.1016\/j.anai.2026.02.005_bib0021","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jaip.2025.12.004","article-title":"Prospective multiregional evaluation of protocol-based penicillin allergy delabeling in china: real-world outcomes challenge mandatory preemptive skin testing policies","volume":"14","author":"Li","year":"2026","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2026.02.005_bib0022","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1302\/0301-620X.107B5.BJJ-2024-1007.R1","article-title":"Labelling patients as allergic to beta-lactam antibiotics is associated with periprosthetic joint infection up to five years following knee arthroplasty","volume":"107-B","author":"Chiang","year":"2025","journal-title":"Bone Jt J"},{"key":"10.1016\/j.anai.2026.02.005_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126849","article-title":"Leveraging COVID-19 vaccine allergy evaluations with coincident drug allergy delabelling: effectiveness and impact on quality of life","volume":"50","author":"Kan","year":"2025","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.anai.2026.02.005_bib0024","article-title":"Bibliometric analysis of the trends and evolution in \u03b2-lactam allergy research","volume":"3","author":"Mak","year":"2024","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"1","key":"10.1016\/j.anai.2026.02.005_bib0025","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jaip.2021.09.013","article-title":"Relabeling of penicillin drug allergy after evaluation in a drug allergy clinic","volume":"10","author":"McDanel","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2026.02.005_bib0026","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaip.2018.04.042","article-title":"Long-term follow-up after penicillin allergy delabeling in ambulatory patients","volume":"7","author":"Lachover-Roth","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2026.02.005_bib0027","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.jaip.2021.01.005","article-title":"Maintaining penicillin allergy delabeling: a quality improvement initiative","volume":"9","author":"Lutfeali","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2026.02.005_bib0028","article-title":"Global differences and risk factors influencing drug hypersensitivity quality of life: a multicenter, multiethnic study of drug allergy across 3 continents","volume":"4","author":"Copaescu","year":"2025","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"6","key":"10.1016\/j.anai.2026.02.005_bib0029","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jaip.2024.02.016","article-title":"Enhancing patient-reported outcome measures for drug hypersensitivity: a validated 6-item quality-of-life questionnaire for patients with drug hypersensitivity","volume":"12","author":"Mak","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2026.02.005_bib0030","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jaip.2025.02.023","article-title":"From statistical to clinical significance: establishing and testing the minimal clinically important difference of the Drug Hypersensitivity Quality of Life Questionnaire (DrHy-Q)","volume":"13","author":"Mak","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2026.02.005_bib0031","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.jaip.2023.03.012","article-title":"Health-related quality of life and mental health in drug hypersensitivity reactions and drug-induced anaphylaxis: a systematic review and meta-analysis","volume":"11","author":"Martini","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2026.02.005_bib0032","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jaip.2014.11.002","article-title":"Improving the effectiveness of penicillin allergy de-labeling","volume":"3","author":"Bourke","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"10.1016\/j.anai.2026.02.005_bib0033","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jhm.2083","article-title":"Risk of redocumenting penicillin allergy in a cohort of patients with negative penicillin skin tests","volume":"8","author":"Rimawi","year":"2013","journal-title":"J Hosp Med"},{"key":"10.1016\/j.anai.2026.02.005_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2022.904923","article-title":"Reconciling allergy information in the electronic health record after a drug challenge using natural language processing","volume":"3","author":"Lo","year":"2022","journal-title":"Front Allergy"},{"issue":"2","key":"10.1016\/j.anai.2026.02.005_bib0035","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/all.16270","article-title":"Impact of a drug allergy education course for non-specialists: findings from ADAPT-a randomized crossover trial","volume":"80","author":"Lucas","year":"2025","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2026.02.005_bib0036","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/cea.70213","article-title":"Bridging global disparities in drug allergy through AI-assisted training for non-specialists: findings from the multinational ADAPT-2 course","volume":"56","author":"Mak","year":"2026","journal-title":"Clin Exp Allergy"},{"issue":"10","key":"10.1016\/j.anai.2026.02.005_bib0037","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/1346-8138.16487","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis associated with increased risk of developing psychiatric disorders: a retrospective population-based cohort study in Taiwan","volume":"49","author":"Chiang","year":"2022","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2026.02.005_bib0038","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cea.14249","article-title":"The impact of anaphylaxis on the quality of life and mental health of adults","volume":"53","author":"Knibb","year":"2023","journal-title":"Clin Exp Allergy"}],"container-title":["Annals of Allergy, Asthma &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626000657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626000657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:42:24Z","timestamp":1793605344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120626000657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1081120626000657"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2026.02.005","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective outcomes of penicillin allergy evaluation","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2026.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}